NACI mandate expands to support local decision-making on vaccine programs

Canada
28 July 2017

In June 2016 the Public Health Agency of Canada (PHAC) announced that the mandate of Canada’s NITAG, the National Advisory Committee on Immunization (NACI) will be expanded. In addition to the assessment of vaccine characteristics (safety, efficacy, effectiveness, and immunogenicity), NACI will also be assessing additional programmatic elements including economic evaluations, feasibility of implementation, acceptability, ethics and equity. 

Flag_of_Canada.png

As vaccine programs are delivered by individual provinces and territories in Canada, integrated and comprehensive guidance from NACI is expected to support local decision making on vaccine programs. The implementation of the expanded NACI mandate will take place over the next few years to facilitate the development of new methods and processes, which are being informed through pilot projects and stakeholder consultations. This work will include the development of guidelines on economic evaluations for vaccines. To support NACI’s expanded mandate, additional committee members have been appointed with expertise in pharmacoeconomics and the NACI Secretariat within PHAC has appointed a health economist. 

Related News & Events

  • Canada

    Introducing NACI newest recommendations regarding the use of Hepatitis B vaccine

    29.03.2017

    NACI have released the update on the recommended use of Hepatitis B vaccine. It includes 4 main recommendations:

    1. NACI does not recommend routine booster doses of HB vaccine for immunocompetent individuals following the completion of a recommended HB immunization schedule given in infancy.
    2. NACI recommends that adults with diabetes need not be considered as a separate high risk group for immunization with HB vaccine.
    3. For immunocompromised individuals, initial annual monitoring of HB antibody levels following HB immunization may be considered
    4. Immunization with HB-containing vaccine should be provided according to determined provincial and territorial (P/T) schedules.
    Read more
  • SAGE

    new Interim Recommendations on Vaccination against Ebola Virus Disease from SAGE

    13.05.2019

    Over the last four weeks, the Ebola outbreak in the Eastern Provinces of the Democratic Republic of Congo (DRC) has deteriorated with a large increase in the number of cases1. A major factor in this rise is an increase in critical security incidents that have dramatically affected the ability to identify, follow up and vaccinate contacts successfully. This context challenges the implementation of ring vaccination based on the identification of contacts and contacts of contacts, as recommended by SAGE in April 2017 and confirmed by SAGE during its April 2019 meeting. Further, a potential vaccine shortage may manifest in case the outbreak expands further and/or is prolonged.

    Read more
  • Network

    Are you the next GNN chair?

    26.03.2019

    The secretariat of the Global NITAG Network is proud to announce an open call for nomination for the new chair for a 2 year mandate.  The vacant will be generated when Pr Anthony Harnden ends his term in June 2019.

    Read more